Zobrazeno 1 - 10
of 84
pro vyhledávání: '"DC Haines"'
Autor:
Birger, Y., Catez, F., Furusawa, T., Jh, Lim, Prymakowska-Bosak, M., Kl, West, Yv, Postnikov, Dc, Haines, Bustin, M.
Publikováno v:
Cancer Research
Cancer Research, American Association for Cancer Research, 2005, pp.6711-6718
Cancer Research, American Association for Cancer Research, 2005, pp.6711-6718
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::b454c97b66af7ee95c276fb6c3ae78b5
https://hal.archives-ouvertes.fr/hal-00153632
https://hal.archives-ouvertes.fr/hal-00153632
Autor:
A Adler, MR Anver, J Beckers, CD Berdanier, D Boggess, F Bonhomme, A Braun, C Brayton, T Buerge, MT Davisson, MH de Angelis, WA de Leeuw, AK Dixon, MM Dorsch, ML Entman, H Ernst, N Everds, NG Frangogiannis, K Fukuta, V Gailus-Durner, K Gärtner, A Gossler, JL Guénet, M Hafner, DC Haines, P Hardy, JH Harlemann, CJ Hartley, HJ Hedrich, R Holmdahl, LM Houdebine, HG Hoymann, T Ichiki, K Imai, B Jilge, Y Kannan, A Kispert, V Komárek, GJ Krinke, E Kunz, CC Linder, M Mähler, LH Michael, I Mikaelian, H Mossmann, W Müller, W Nicklas, K Otto, RE Price, M Ritskes-Hoitinga, S Rittinghausen, R Seymour, S Shimizu, KA Silva, D Soewarto, JP Sundberg, GE Taffet, S Wagner, JM Ward, T Weiss
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::172c3b970916d33319bc7f0d58b8589a
https://doi.org/10.1016/b978-012336425-8/50051-0
https://doi.org/10.1016/b978-012336425-8/50051-0
Publikováno v:
Europe PubMed Central
Mice lacking the Gadd45a gene are susceptible to ionizing radiation-induced tumors. Increased levels of Gadd45a transcript and protein are seen after treatment of cells with ionizing radiation as well as many other agents and treatments that damage D
Autor:
Houser T, Lindgren KN, Mazuchowski EL 2nd, Barratt MR, Haines DC, Jayakody M, Blue RS, Bytheway JA, Stepaniak PC
Publikováno v:
Aerospace medicine and human performance [Aerosp Med Hum Perform] 2023 May 01; Vol. 94 (5), pp. 368-376.
Autor:
Szot C; Tumor Angiogenesis Unit, Mouse Cancer Genetics Program (MCGP), National Cancer Institute (NCI), NIH, Frederick, Maryland, USA., Saha S; BioMed Valley Discoveries Inc., Kansas City, Missouri, USA., Zhang XM; BioMed Valley Discoveries Inc., Kansas City, Missouri, USA., Zhu Z; Tumor Angiogenesis Unit, Mouse Cancer Genetics Program (MCGP), National Cancer Institute (NCI), NIH, Frederick, Maryland, USA.; Protein Interactions Section, Cancer and Inflammation Program, NCI, NIH, Frederick, Maryland, USA., Hilton MB; Tumor Angiogenesis Unit, Mouse Cancer Genetics Program (MCGP), National Cancer Institute (NCI), NIH, Frederick, Maryland, USA.; Basic Research Program, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research (FNLCR), Frederick, Maryland, USA., Morris K; Tumor Angiogenesis Unit, Mouse Cancer Genetics Program (MCGP), National Cancer Institute (NCI), NIH, Frederick, Maryland, USA.; Basic Research Program, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research (FNLCR), Frederick, Maryland, USA., Seaman S; Tumor Angiogenesis Unit, Mouse Cancer Genetics Program (MCGP), National Cancer Institute (NCI), NIH, Frederick, Maryland, USA., Dunleavey JM; Tumor Angiogenesis Unit, Mouse Cancer Genetics Program (MCGP), National Cancer Institute (NCI), NIH, Frederick, Maryland, USA., Hsu KS; Tumor Angiogenesis Unit, Mouse Cancer Genetics Program (MCGP), National Cancer Institute (NCI), NIH, Frederick, Maryland, USA., Yu GJ; Tumor Angiogenesis Unit, Mouse Cancer Genetics Program (MCGP), National Cancer Institute (NCI), NIH, Frederick, Maryland, USA., Morris H; Transgenic Core Facility, MCGP, NCI, Frederick, Maryland, USA., Swing DA; Transgenic Core Facility, MCGP, NCI, Frederick, Maryland, USA., Haines DC; Veterinary Pathology Section, Pathology/Histotechnology Laboratory, Leidos Biomedical Research Inc., FNLCR, Frederick, Maryland, USA., Wang Y; Protein Interactions Section, Cancer and Inflammation Program, NCI, NIH, Frederick, Maryland, USA., Hwang J; Protein Interactions Section, Cancer and Inflammation Program, NCI, NIH, Frederick, Maryland, USA., Feng Y; Tumor Angiogenesis Unit, Mouse Cancer Genetics Program (MCGP), National Cancer Institute (NCI), NIH, Frederick, Maryland, USA.; Protein Interactions Section, Cancer and Inflammation Program, NCI, NIH, Frederick, Maryland, USA., Welsch D; BioMed Valley Discoveries Inc., Kansas City, Missouri, USA., DeCrescenzo G; BioMed Valley Discoveries Inc., Kansas City, Missouri, USA., Chaudhary A; Tumor Angiogenesis Unit, Mouse Cancer Genetics Program (MCGP), National Cancer Institute (NCI), NIH, Frederick, Maryland, USA., Zudaire E; Tumor Angiogenesis Unit, Mouse Cancer Genetics Program (MCGP), National Cancer Institute (NCI), NIH, Frederick, Maryland, USA., Dimitrov DS; Protein Interactions Section, Cancer and Inflammation Program, NCI, NIH, Frederick, Maryland, USA., St Croix B; Tumor Angiogenesis Unit, Mouse Cancer Genetics Program (MCGP), National Cancer Institute (NCI), NIH, Frederick, Maryland, USA.
Publikováno v:
The Journal of clinical investigation [J Clin Invest] 2018 Jul 02; Vol. 128 (7), pp. 2927-2943. Date of Electronic Publication: 2018 Jun 04.
Autor:
Antony S; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Jiang G; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland., Wu Y; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland., Meitzler JL; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland., Makhlouf HR; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Haines DC; Pathology/Histotechnology Laboratory, Leidos Inc./Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, Maryland., Butcher D; Pathology/Histotechnology Laboratory, Leidos Inc./Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, Maryland., Hoon DS; Department of Molecular Oncology, John Wayne Cancer Institute, Santa Monica, California., Ji J; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Zhang Y; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Juhasz A; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland., Lu J; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland., Liu H; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Dahan I; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Konate M; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Roy KK; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Doroshow JH; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland.; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
Publikováno v:
Molecular carcinogenesis [Mol Carcinog] 2017 Dec; Vol. 56 (12), pp. 2643-2662. Date of Electronic Publication: 2017 Aug 30.
Autor:
Juhasz A; From the Developmental Therapeutics Branch of the Center for Cancer Research., Markel S; the Department of Medical Oncology and Therapeutics Research and., Gaur S; the Department of Medical Oncology and Therapeutics Research and., Liu H; the Division of Cancer Treatment and Diagnosis, NCI, National Institutes of Health, Bethesda, Maryland 20892., Lu J; From the Developmental Therapeutics Branch of the Center for Cancer Research., Jiang G; From the Developmental Therapeutics Branch of the Center for Cancer Research., Wu X; the Bioinformatics Group, City of Hope Comprehensive Cancer Center, Duarte, California 91010., Antony S; From the Developmental Therapeutics Branch of the Center for Cancer Research., Wu Y; From the Developmental Therapeutics Branch of the Center for Cancer Research., Melillo G; the Developmental Therapeutics Program, SAIC-Frederick, Inc., NCI at Frederick, Frederick, Maryland 21702, and., Meitzler JL; From the Developmental Therapeutics Branch of the Center for Cancer Research., Haines DC; the Pathology/Histotechnology Laboratory, Leidos, Inc./Frederick National Laboratory for Cancer Research, NCI, Frederick, Maryland 21702., Butcher D; the Pathology/Histotechnology Laboratory, Leidos, Inc./Frederick National Laboratory for Cancer Research, NCI, Frederick, Maryland 21702., Roy K; the Division of Cancer Treatment and Diagnosis, NCI, National Institutes of Health, Bethesda, Maryland 20892., Doroshow JH; From the Developmental Therapeutics Branch of the Center for Cancer Research, doroshoj@mail.NIH.gov.; the Division of Cancer Treatment and Diagnosis, NCI, National Institutes of Health, Bethesda, Maryland 20892.
Publikováno v:
The Journal of biological chemistry [J Biol Chem] 2017 May 12; Vol. 292 (19), pp. 7866-7887. Date of Electronic Publication: 2017 Mar 22.
Autor:
Yang Y; Lab of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Yang HH; High Dimension Data Analysis Group, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Hu Y; High Dimension Data Analysis Group, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Watson PH; British Columbia Cancer Agency, Vancouver Island Center, Victoria, British Columbia, Canada., Liu H; High Dimension Data Analysis Group, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Geiger TR; Lab of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Anver MR; Pathology Histotechnology Lab, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick MD, USA., Haines DC; Pathology Histotechnology Lab, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick MD, USA., Martin P; Pathology Histotechnology Lab, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick MD, USA., Green JE; Lab of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Lee MP; High Dimension Data Analysis Group, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Hunter KW; Lab of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Wakefield LM; Lab of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
Publikováno v:
Oncotarget [Oncotarget] 2017 May 09; Vol. 8 (19), pp. 30621-30643.
Autor:
Song Y; Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America., Sullivan T; Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America., Klarmann K; Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America.; Basic Science Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America., Gilbert D; Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America., O'Sullivan TN; Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America., Lu L; Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America., Wang S; Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America., Haines DC; Pathology/ Histotechnology Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America., Van Dyke T; Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America., Keller JR; Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America.; Basic Science Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Publikováno v:
PloS one [PLoS One] 2017 Feb 03; Vol. 12 (2), pp. e0171510. Date of Electronic Publication: 2017 Feb 03 (Print Publication: 2017).
Autor:
Hasumi H; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.; Department of Urology and Molecular Genetics, Yokohama City University, Yokohama, Japan., Hasumi Y; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Baba M; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.; International Research Center for Medical Sciences, Kumamoto University, Kumamoto, Japan., Nishi H; Department of Applied Information Science, Tohoku University, Sendai, Japan., Furuya M; Department of Molecular Pathology, Yokohama City University, Yokohama, Japan., Vocke CD; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Lang M; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Irie N; International Research Center for Medical Sciences, Kumamoto University, Kumamoto, Japan., Esumi C; International Research Center for Medical Sciences, Kumamoto University, Kumamoto, Japan., Merino MJ; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Kawahara T; Department of Urology and Molecular Genetics, Yokohama City University, Yokohama, Japan., Isono Y; Department of Otorhinolaryngology, Head and Neck Surgery, Yokohama City University, Yokohama, Japan., Makiyama K; Department of Urology and Molecular Genetics, Yokohama City University, Yokohama, Japan., Warner AC; Pathology/Histotechnology Laboratory., Haines DC; Pathology/Histotechnology Laboratory., Wei MH; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Zbar B; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Hagenau H; Laboratory Animal Sciences Program., Feigenbaum L; Laboratory Animal Sciences Program., Kondo K; Department of Urology and Molecular Genetics, Yokohama City University, Yokohama, Japan., Nakaigawa N; Department of Urology and Molecular Genetics, Yokohama City University, Yokohama, Japan., Yao M; Department of Urology and Molecular Genetics, Yokohama City University, Yokohama, Japan., Metwalli AR; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Marston Linehan W; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Schmidt LS; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.; Basic Science Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Publikováno v:
Human molecular genetics [Hum Mol Genet] 2017 Jan 15; Vol. 26 (2), pp. 354-366.